Two more Wall Street firms are keeping an eye on Exact Sciences Corp., the Madison company working on a stool-based, non-invasive test for colorectal cancer. Read the full Wisconsin State Journal story here.
- WisBusiness: The Podcast features LÜM CEO Max FergusSeptember 17, 2021
- $175 million commitment helps launch UW–Madison School of Computer, Data & Information Sciences, support transformative missionSeptember 17, 2021
- WisconsinINNO: Matchstick Ventures closes on $55 million third fundSeptember 16, 2021
- Healthcare challenges topic at Sept. 30 W·O·M·E·N reception with Dr. Susan TurneySeptember 16, 2021
- InsideWis: Calling all early stage companies: Conference can help firms connect with investorsSeptember 16, 2021